Related references
Note: Only part of the references are listed.The tyrosine phosphatase Shp2 (PTPN11) in cancer
Gordon Chan et al.
CANCER AND METASTASIS REVIEWS (2008)
The RAS/MAPK syndromes: Novel roles of the RAS pathway in human genetic disorders
Yoko Aoki et al.
HUMAN MUTATION (2008)
A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor
Chang Hoon Ha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome
Maike Krenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development
Jason Newbern et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mediating ERK1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome
Tomoki Nakamura et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A critical role for the EphA3 receptor tyrosine kinase in heart development
Lesley J. Stephen et al.
DEVELOPMENTAL BIOLOGY (2007)
Erlotinib directly inhibits HER2 kinase activation and downstream signaling events in intact cells lacking epidermal growth factor receptor expression
Gabriele Schaefer et al.
CANCER RESEARCH (2007)
Development of heart valves requires Gata4 expression in endothelial-derived cells
Jose Rivera-Feliciano et al.
DEVELOPMENT (2006)
Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1/2 signaling
M Krenz et al.
CIRCULATION RESEARCH (2005)
Diverse biochemical properties of Shp2 mutants
H Keilhack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lineage and morphogenetic analysis of the cardiac valves
FJ de Lange et al.
CIRCULATION RESEARCH (2004)
Heart valve development - Endothelial cell signaling and differentiation
EJ Armstrong et al.
CIRCULATION RESEARCH (2004)
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation
T Araki et al.
NATURE MEDICINE (2004)
Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt
R Fukazawa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation
Y Sugi et al.
DEVELOPMENTAL BIOLOGY (2003)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
M Tartaglia et al.
NATURE GENETICS (2003)
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
BG Neel et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Nf1 has an essential role in endothelial cells
AD Gitler et al.
NATURE GENETICS (2003)
PTPN11 mutations in Noonan syndrome:: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity
M Tartaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3
V Gaussin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
